Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: A meta-analysis of randomized controlled trials

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 5, 2014, Pages 470-475

  Wen, Y T ^a   Dai, J H ^b   Gao, Q ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Coronary heart disease; Major cardiovascular events; Meta analysis; Omega 3 polyunsaturated fatty acids; Randomized controlled trials

Indexed keywords

OMEGA 3 FATTY ACID; PLACEBO;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; HEART INFARCTION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; SENSITIVITY ANALYSIS; SUDDEN CARDIAC DEATH; UNSTABLE ANGINA PECTORIS; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; DIET SUPPLEMENTATION; FACTUAL DATABASE; MORTALITY;

CORONARY DISEASE; DATABASES, FACTUAL; DEATH, SUDDEN, CARDIAC; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84899108394     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.12.004     Document Type: Article

References (36)

1. Wall R., Ross R.P., Fitzgerald G.F., Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010, 68:280-289.
2. World Health Organization Diet, nutrition and the prevention of chronic diseases 2013, Report of the Joint WHO/FAO Expert Consultation, [accessed 23.06.13]. http://www.who.int/dietphysicalactivity/publications/trs916/download/en/.
3. Kris-Etherton P.M., Harris W.S., Appel L.J. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 2003, 23:151-152.
4. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999, 354:447-455. GISSI-Prevenzione Investigators.
5. Tavazzi L., Maggioni A.P., Marchioli R., Barlera S., Franzosi M.G., Latini R., et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1223-1230.
6. Matsuzaki M., Yokoyama M., Saito Y., Origasa H., Ishikawa Y., Oikawa S., et al. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J 2009, 73:1283-1290.
7. Kromhout D., Giltay E.J., Geleijnse J.M. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010, 363:2015-2026.
8. Rauch B., Schiele R., Schneider S., Diller F., Victor N., Gohlke H., et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010, 122:2152-2159.
9. Bosch J., Gerstein H.C., Dagenais G.R., Diaz R., Dyal L., Jung H., et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012, 367:309-318.
10. Burdge G.C., Finnegan Y.E., Minihane A.M., Williams C.M., Wootton S.A. Effect of altered dietary n-3 fatty acid intake upon plasma lipid fatty acid composition, conversion of [13C]alpha-linolenic acid to longer-chain fatty acids and partitioning towards beta-oxidation in older men. Br J Nutr 2003, 90:311-321.
11. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
12. Carney R.M., Freedland K.E., Rubin E.H., Rich M.W., Steinmeyer B.C., Harris W.S. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. J Am Med Assoc 2009, 302:1651-1657.
13. Durrington P.N., Bhatnagar D., Mackness M.I., Morgan J., Julier K., Khan M.A., et al. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart 2001, 85:544-548.
14. Gajos G., Rostoff P., Undas A., Piwowarska W. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study. J Am Coll Cardiol 2010, 55:1671-1678.
15. Johansen O., Brekke M., Seljeflot I., Abdelnoor M., Arnesen H. N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol 1999, 33:1619-1626.
16. Leaf A., Jorgensen M.B., Jacobs A.K., Cote G., Schoenfeld D.A., Scheer J., et al. Do fish oils prevent restenosis after coronary angioplasty?. Circulation 1994, 90:2248-2257.
17. Nilsen D.W., Albrektsen G., Landmark K., Moen S., Aarsland T., Woie L. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr 2001, 74:50-56.
18. Sacks F.M., Stone P.H., Gibson C.M., Silverman D.I., Rosner B., Pasternak R.C. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol 1995, 25:1492-1498.
19. Singh R.B., Niaz M.A., Sharma J.P., Kumar R., Rastogi V., Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther 1997, 11:485-491.
20. von Schacky C., Angerer P., Kothny W., Theisen K., Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 130:554-562.
21. Mori T.A., Beilin L.J. Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Curr Opin Lipidol 2001, 12:11-17.
22. Kromhout D., Yasuda S., Geleijnse J.M., Shimokawa H. Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?. Eur Heart J 2012, 33:436-443.
23. Rizos E.C., Ntzani E.E., Bika E., Kostapanos M.S., Elisaf M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. J Am Med Assoc 2012, 308:1024-1033.
24. Leon H., Shibata M.C., Sivakumaran S., Dorgan M., Chatterley T., Tsuyuki R.T. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 2008, 337:a2931.
25. Kwak S.M., Myung S.K., Lee Y.J., Seo H.G. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 2012, 172:686-694.
26. Marik P.E., Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 2009, 32:365-372.
27. Ferrari R. Revising common beliefs in the management of stable CAD. Nat Rev 2013, 10:65-66.
28. Mozaffarian D., Wu J.H. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011, 58:2047-2067.
29. Laufs U., Schirmer S.H. Margarines supplemented with low dose n-3 fatty acids are not effective in secondary prevention. Eur Heart J 2012, 33:1555-1557.
30. Christensen J.H., Christensen M.S., Dyerberg J., Schmidt E.B. Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am J Clin Nutr 1999, 70:331-337.
31. Mozaffarian D., Geelen A., Brouwer I.A., Geleijnse J.M., Zock P.L., Katan M.B. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 2005, 112:1945-1952.
32. Brouwer I.A., Katan M.B., Zock P.L. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 2004, 134:919-922.
33. Augustsson K., Michaud D.S., Rimm E.B., Leitzmann M.F., Stampfer M.J., Willett W.C., et al. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev 2003, 12:64-67.
34. Fabian C.J., Kimler B.F. Marine-derived omega-3 fatty acids. Am Soc Clin Oncol Educ Book 2013, 2013:97-101.
35. Cockbain A.J., Toogood G.J., Hull M.A. Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut 2012, 61:135-149.
36. Vaughan V.C., Hassing M.R., Lewandowski P.A. Marine polyunsaturated fatty acids and cancer therapy. Br J Cancer 2013, 108:486-492.